The main objective of this review is to investigate the potential role of milk in improvement of bioavailability and patient compliance. Method: The study reviews the types of milk based on its composition, mechanism of how milk improves the solubility of poorly soluble drugs, masks the taste of bitter drugs and improves the patient compliance to dosage regimen. It also reviews various research studies done so far that recommend the use of milk in formulations. Along with this, the regulatory aspect of using milk is also considered in the present study. Conclusion: Investigation concludes that medicated milk formulations open a new hope of utilizing milk as multi-functional drug carrier for a variety of drugs.
INTRODUCTION
Despite of tremendous advancement in drug delivery systems, oral route is the most preferred route of administration and hence tablets and capsules are the most preferred dosage forms. However, the drugs having aqueous solubility less than 0.1 mg/ml at 37°C pose a major problem for phar maceutical scientists. Now since nearly 40% of the drugs identified by the pharmaceutical industry are found to be poorly water soluble, 1 it becomes a great challenge to formulate these drugs (e.g. NSAIDs, Anti biotics, Anticancer drugs, Antiretroviral drugs etc.) into oral dosage forms owing to their poor aqueous solubility and thus poor bioavailability. In addition, their bitter taste and associated gastric irritation make them less acceptable and thus lead to poor patient compliance especially in paedriatic patients. Therefore, the improvement of solubility and hence the bioavailability is the first and foremost target which can be achieved by modifying the crystallinity and nonpolarity of such drugs. 2 Some modern approaches which can be used are solid dispersions, 3 microni zation, 4 salt formation, modification of crystal habit, 5, 6 polymeric alte rations and inclusion complexes, 7 spray drying, 8 solvent evaporation method, high pressure homogenization and lyophilization technique. 9 The modification of the dissolution media in which drug is dissolved may also improve the dissolution rate. It can be achieved either by adjusting the pH or by adding cosolvents, 10 complexing agents, 11 solu bilizing agents 12 and surfactants. 13 To some extent, the above mentioned methods do take care of solubility and bioavailability related challenges, however, they don't avoid some inevitable side effects like gastric irritation, abdominal pain, nausea and diarrhoea. It has been disclosed in many published studies that milk offers a great solution to the above mentioned challenges without any noticeable side effect. Use of milk as a dispersion carrier in pharmaceutical formulations offers following benefits: 1. Solubility of lipophilic drugs both in ionized as well as unionized forms, is higher in milk than their aqueous solubility.
2. Due to its taste masking ability, milk can be a good carrier for bitter drugs especially in pediatric patients. 3. Milk, due to its natural properties, is able to remediate the gastric side effects to a great extent. 4. Milk is naturally occurring oilinwater emulsion which is inexpensive and is available abundantly.
Classification of Milk
Based on the content of fat present, milk can be classified into 3 main categories namely full fat milk; semi skilled milk and skimmed milk. Other than fats, milk contains a rich content of protein and carbohydrate also. Composition of above classified categories of milk along with calories of energies it carries is given in Table 1 .
Composition Based Mechanism of Milk
The composition of milk varies due to differences in relative rates of synthesis and secretion of the milk component by the mammary gland. The mammary epithelial cells secrete milk as fat globules whose average size is 3 µm in diameter but can vary from 118 µm. These fat globules are encapsulated by a lipid bilayer membrane which consists of proteins, phospholipids, lipoproteins, cerebrosides, nucleic acids, enzymes, trace elements and bound water. The fat globule in the aqueous environment of the milk serum is stabilized by the FGM (Fat Globule Membrane). The fat contained in the milk belong to the group of esters, which are composed of alcohol and acids. 15 There are two different types of protein present in milk casein and whey. Casein consists of 80% of total protein content and is further classified into five categories as alpha s1 , alpha s2 , beta, gamma and kappa caseins. Casein acts as highly effective surface active agent owing to presence of hydropho bic as well as hydrophilic regions in its amino acids. 15 Whey proteins pres ent in milk such as βlactoglobulin, αlactoalbumin, bovine serum albu min and immunoglobulins have better solubility as compared to caseins. 16 Most of casein proteins present in skimmed milk exist in a colloidal particle state as the casein micelle. It has been observed that hydrophobic drug is entrapped by the casein micelles. Due to their surface active properties, there is an improvement in the solubility of the drug sub stance in gastric media when administered orally. These micelles have a porous structure which helps in the release of entrapped drug molecules from the inclusion complex into the dissolution media. 17, 18 In addition to casein micelle, casein submicelle model was also suggested according to which, there exist small aggregates of whole casein which contain 10100 casein molecules known as submicelles. Based upon the presence or absence of kappa casein, two different types of submicelles are assumed: with and without kappa casein. These submicelles are composed of a hydro phobic core and have a hydrophilic coating which is partly comprised of kappacasein, polar moieties that exhibit surface activity. 19, 20 Some studies showing the utility of milk in overcoming solubility problems, gastric irritation and bitter taste of drugs are quoted here.
The solubility of lipophilic drug in powdered form is much higher in milk as compared its aqueous solubility. 21 Use of skimmed milk is also preferred over polymers in case of poorly soluble or lipophilic drugs because of their own high viscosity. 16 It also represses gastric irritation and hence no abdominal pain is noticed with the use of milk as a dispersion medium with NSAIDs. 22 NSAIDs are advised to be administered with milk to reduce the side effects that appear with their use like gastric irritation which is due to COX inhibition.
In another study, a novel nipple shield delivery system (NSDS) for anti retroviral drug administration to infants during breast feeding was prepared. 23 The API released directly into milk during breastfeeding.
This study investigated the feasibility of using the NSDS to deliver the microbicide sodium dodecyl sulfate (SDS), with the goal of preventing mothertochild transmission (MTCT) of HIV during breastfeeding in lowresource settings, in the absence of safer alternative for the infant but to breastfeed. This proof of concept study demonstrated that efficient drug delivery to breastfeeding infants was achievable using the NSDS.
A number of other invitro and in-vivo studies with milk formulations of different active substance have shown their superiority in terms of dissolution and solubility. 24 In 1987, Dial et al. studied antiulcer activity of pasteurized bovine milk and its lipid extract using 0.6N HCl, absolute ethanol and acidified bile acid as ulcerogenic agents in rats. Their ulcerogenic effects were signifi cantly pacified with prior administration of milk. The lipid content of milk such as prostaglandins and phospholipids were observed to have potent antiulcer activity. This activity of milk is due to its ability to main tain the hydrophobicity of the gastric lumen by maintaining the major phospholipids in their cationic form which promote their adsorption to the negatively charged mucosal surface. Protein content present in milk was observed to be responsible for stimulant action on acidic secretions and hence for the maintenance of an acidic environment within the gastric lumen. The phospholipid content of skim milk is about 40% that of whole milk and buttermilk is about 300% that of whole milk. This phos pholipid content in milk products was directly related to the protective efficacy. From this study, it was concluded that when 0.6 N HCl was used as a damaging agent in pylorus ligated rats, the protective active activity of milk was found to be due to its phospholipid content, rather than protein content. 25 In 1995, Dial et al. studied the ability of dairy foods such as whole milk 3.5% fat, skimmed milk 0% fat and cream 35% fat, to prevent bleeding and stress induced gastric lesions in rats. From this study Dial concluded that cream owing to its high fat content provided the greatest protection whereas the nonfat milk provided lowest protection. 26 
Milk Based Formulations
The main aim of developing milk as a dispersing carrier is invivo solu bilization of sparingly soluble active ingredients and thus to enhance the bioavailability of ionized and unionized lipophilic drugs. 1 So, the manufacturing of these formulations can be achieved by using three approaches: 16 
Solution of moderately water soluble drug from an effervescent tablet
is prepared by using small volume of water ( ≈ 20 ml). Then this dissolved drug is incorporated into a specific volume of milk which may be administered instantly or undergoes further processing before administration. This method of manufacturing is appropriate for several chemically as well as pharmacologically different drugs which include OTC (over the counter) and widely prescribed drugs like non steroidal antiinflammatory drugs viz. Meloxicam, Tenoxicam, Nimesu lide, Mefanamic acid, Tolfenamic acid, Ketoprufen and Ibuprofen. Other such drugs include antiretroviral agents, several antibiotics and anti cancer agents. 27, 28 Table 3 briefly summarizes the milk based formulations, the tech niques used therein to formulate them and the results obtained with the formulations.
Regulatory Aspects
Milk based formulations are considered as a novel, simple and physio logically friendly approach for the delivery of lipophilic drugs. The strong buffering capacity of milk makes the use of alkaline buffers of nonsteroidal antiinflammatory drugs possible in these formulations to accommodate the therapeutic doses of NSAIDs. For this reason, this approach can be considered universal for ionized as well as unionized lipophilic drugs. 16 Milk has not been officially registered as an excipient from a regulatory aspect; but casein which is considered as a major protein present in the milk is included in the list of Generally Recognized as Safe (GRAS) substance. 1 GRAS certifications and notices exhibit FDA's confidence in the safety of the milkderived ingredients.
GRAS submitted information in the following areas: 40 • The identity and specifications for the concentrated milk proteins • The manufacturing process for the concentrated milk proteins • The intended use and an estimation of consumption of the concen trated milk
CONCLUSION
Milk is highly nutritious drink with rich content of nutritive elements and a wide range of biologically active peptides. Milk made formulations provide a simple, novel and patient friendly approach for the delivery of ionized as well unionized hydrophobic drugs. Incorporation of milk in the formulation results in solubilization of drugs with enhanced pharma cokinetic properties. Taste masking and gastroprotective properties also prove it a promising carrier for drugs. Further in-vitro studies are yet to be to be carried out to elucidate the colloidal stability of resulting emulsion, particle size and distribution of milk component. Also the use of lactose free milk for these formulations is still to be explored for patience with lactose intolerance. Finally these medicated milk formulations open a new hope of using milk as a natural dispersing agent and a broad spectrum drug carrier for a variety of drugs.
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